Particle.news
Download on the App Store

NHS and MHRA Warn Against Social Media Weight‑Loss Jabs After Poll Flags Buyer Interest

Officials cite fake or unapproved products sold without clinical oversight that pose serious risks.

Overview

  • An Ipsos survey of 2,161 adults found 9% would buy weight‑loss injections via social platforms if they could not get a prescription, with 5% willing to use a non‑registered online retailer.
  • NHS England’s Dr Claire Fuller urged people not to seek quick fixes online, stressing that powerful weight‑loss medicines require proper assessment, monitoring and follow‑up care.
  • The MHRA warned that products sold illegally online may be fake, contaminated or incorrectly dosed, and could contain undisclosed ingredients that cause dangerous side effects.
  • The Independent reported dozens of social media accounts purporting to sell Retatrutide, an unapproved drug still in clinical trials and not authorised for human use.
  • The National Pharmacy Association expects a New Year surge in demand and reports cases of fake pens containing insulin leading to hypoglycaemic emergencies, urging patients to use regulated pharmacies.